| Company
| InsiderPie Expert Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Intelligent Bio Solutions Inc.
|
50
/ 100
| -0.04
| 43.1%
| -331.7%
| -108.2%
| -€185.07K
|
| Vimian Group AB (publ)
|
50
/ 100
| 6.1
| 68.6%
| 14.3%
| 2.8%
| €26.08K
|
| Fulgent Genetics, Inc.
|
50
/ 100
| -15
| 41.2%
| -22.5%
| -3.5%
| -€27.88K
|
| Lumibird SA
|
50
/ 100
| 17
| 22.1%
| 9.1%
| 4.0%
| €16.78K
|
| NanoRepro AG
|
50
/ 100
| -3.1
| 40.3%
| -115.2%
| -17.2%
| -€305.96K
|
| Exagen Inc.
|
53
/ 100
| -8.4
| 59.9%
| -19.6%
| -30.3%
| -€77.58K
|
| Verici Dx plc
|
50
/ 100
| -0.0038
| 99.9%
| -344.0%
| -195.0%
| -€654.78K
|
| Proteome Sciences plc
|
50
/ 100
| -0.012
| 99.9%
| 25.2%
| -88.8%
| -€237.14K
|
| Illumina, Inc.
|
61
/ 100
| 20
| 66.2%
| 18.3%
| 11.4%
| €66.75K
|
| IDEXX Laboratories, Inc.
|
72
/ 100
| 41
| 61.7%
| 31.3%
| 30.3%
| €79.55K
|
| Yourgene Health Plc
|
50
/ 100
| -0.014
| 61.1%
| -62.8%
| -23.1%
| -€51.62K
|
| Syneos Health, Inc.
|
50
/ 100
| 63
| 22.1%
| 5.4%
| 0.9%
| €2.11K
|
| Myriad Genetics, Inc.
|
52
/ 100
| -1.2
| 70.4%
| -50.1%
| -58.3%
| -€124.66K
|
| Exact Sciences Corporation
|
56
/ 100
| -11
| 67.4%
| -32.3%
| -16.7%
| -€121.77K
|
| Spectral Medical Inc.
|
49
/ 100
| -12
| 59.8%
| -461.5%
| -389.0%
| -€456.16K
|
| OpGen, Inc.
|
50
/ 100
| 6.2
| 98.9%
| 78.9%
| 54.1%
| €68.56K
|
| Medpace Holdings, Inc.
|
57
/ 100
| 20
| 31.1%
| 21.5%
| 24.7%
| €62.50K
|
| Standard BioTools Inc.
|
50
/ 100
| -3.2
| 47.9%
| -96.6%
| -23.8%
| -€134.18K
|
| Waters Corporation
|
71
/ 100
| 32
| 62.4%
| 26.5%
| 13.3%
| €72.70K
|
| Trinity Biotech plc
|
50
/ 100
| -0.35
| 32.1%
| -42.0%
| -37.4%
| -€83.54K
|
| Meridian Bioscience, Inc.
|
50
/ 100
| -553
| 56.6%
| 2.1%
| -0.6%
| -€3.33K
|
| Interpace Biosciences, Inc.
|
50
/ 100
| 0.76
| 64.6%
| 13.3%
| 40.0%
| €36.90K
|
| Mettler-Toledo International Inc.
|
61
/ 100
| 30
| 59.7%
| 29.1%
| 23.7%
| €44.48K
|
| Star Equity Holdings, Inc.
|
47
/ 100
| -1
| 32.9%
| -1.8%
| -5.4%
| -€27.77K
|
| Precipio, Inc.
|
50
/ 100
| -13
| 47.5%
| -9.7%
| -5.9%
| -€19.78K
|
| PerkinElmer, Inc.
|
50
/ 100
| 46
| 59.1%
| 12.0%
| 2.0%
| €12.51K
|
| ANGLE plc
|
47
/ 100
| -1.1
| 62.3%
| -627.7%
| -87.3%
| -€121.18K
|
| Synlab AG
|
50
/ 100
| 27
| 49.8%
| 5.2%
| 1.9%
| €3.31K
|
| OPKO Health, Inc.
|
48
/ 100
| -7.6
| 38.6%
| -17.5%
| -7.1%
| -€40.01K
|
| Bionano Genomics, Inc.
|
50
/ 100
| -0.32
| 48.1%
| -127.9%
| -48.8%
| -€335.33K
|
| Biocartis Group NV
|
50
/ 100
| -0.21
| 37.6%
| -89.6%
| -117.2%
| -€251.66K
|
| Applied DNA Sciences, Inc.
|
50
/ 100
| -0.065
| 39.6%
| -406.1%
| -373.5%
| -€686.96K
|
| Danaher Corporation
|
76
/ 100
| 42
| 59.5%
| 19.0%
| 4.4%
| €48.91K
|
| IQVIA Holdings Inc.
|
53
/ 100
| 21
| 33.8%
| 13.4%
| 4.5%
| €12.28K
|
| Diaceutics PLC
|
50
/ 100
| -0.24
| 81.4%
| -11.0%
| -9.8%
| -€27.33K
|
| Neuronetics, Inc.
|
49
/ 100
| -5.7
| 50.4%
| -29.2%
| -30.2%
| -€52.33K
|
| RadNet, Inc.
|
56
/ 100
| -343
| 9.6%
| 3.0%
| -0.3%
| -€984.04
|
| Eurofins Scientific SE
|
51
/ 100
| 19
| 11.7%
| 11.5%
| 5.3%
| €9.01K
|
| Lonza Group AG
|
51
/ 100
| 31
| 31.1%
| 16.8%
| 6.9%
| €78.23K
|
| CareDx, Inc
|
51
/ 100
| 18
| 67.3%
| 14.7%
| 14.1%
| €80.36K
|
| Invitae Corporation
|
48
/ 100
| -0.0038
| 27.1%
| -303.5%
| -269.2%
| -€721.70K
|
| Twist Bioscience Corporation
|
57
/ 100
| -27
| 50.7%
| -36.2%
| -12.1%
| -€71.52K
|
| Guardant Health, Inc.
|
57
/ 100
| -15
| 63.8%
| -49.0%
| -31.2%
| -€169.90K
|
| Neogen Corporation
|
49
/ 100
| -1.2
| 43.8%
| -121.7%
| -30.9%
| -€304.54K
|
| MDxHealth SA
|
50
/ 100
| -3.1
| 63.1%
| -26.7%
| -24.9%
| -€132.25K
|
| DiaSorin S.p.A.
|
51
/ 100
| 27
| 65.7%
| 23.1%
| 6.6%
| €58.60K
|
| Thermo Fisher Scientific Inc.
|
66
/ 100
| 24
| 42.0%
| 17.2%
| 6.4%
| €44.76K
|
| Personalis, Inc.
|
50
/ 100
| -7
| 26.7%
| -117.1%
| -30.4%
| -€275.97K
|
| Charles River Laboratories International, Inc.
|
55
/ 100
| -89
| 32.1%
| 3.5%
| -1.1%
| -€3.80K
|
| Agilent Technologies, Inc.
|
62
/ 100
| 26
| 52.4%
| 21.3%
| 10.2%
| €61.99K
|
